Have a personal or library account? Click to login
Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision Cover

Consensus molecular subtypes (CMS) in metastatic colorectal cancer - personalized medicine decision

Open Access
|May 2020

Figures & Tables

Classification of consensus molecular subtypes (CMS)_ Adopted by Guiney et al_7

CMS subtypeCMS1 -MSI immuneCMS2 - CanonicalCMS3 – MetabolicCMS4 - Mesenchymal
Frequency14%37%13%23%
MSI, CIMP high, hypermutationSCNA highMixed MSI CIMP status, low SCNA low,SCNA high
BRAF mutationKRAS mutation
CharacteristicsImmune infiltration and activationWNT and MYC activationMetabolic deregulationStromal infiltration, TGF-β activation, angiogenesis
Worse survival after relapseWorse relapse- free and overall survival
DOI: https://doi.org/10.2478/raon-2020-0031 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 272 - 277
Submitted on: Mar 13, 2020
|
Accepted on: Apr 29, 2020
|
Published on: May 28, 2020
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2020 Martina Rebersek, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.